Pharmaceuticals, Biotechnology and Life Sciences
Serial entrepreneur and computer scientist Bryan Brandenburg advances biomedical and life extension simulation and visualization AI technologies at the helm…
RALEIGH, N.C.–(BUSINESS WIRE)–Arrevus Inc. (www.arrevus.com), a biotechnology company developing novel therapeutics for patients with unmet medical needs, today announced the…
NOTTINGHAM, England–(BUSINESS WIRE)–Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that…
Dendreon has completed enrollment of of 450 patients, in Phase 3 ProVent clinical trial testing Sipuleucel-T in men on active…
Providing new patient treatment options, accelerating development of life-changing medicines
Hemlibra was approved for hemophilia A without inhibitors in Taiwan on 22 October 2019.
– Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed…
NMOSD is a rare disease where repeated relapses may result in visual impairment and motor disability in the course of…
Cellectis has had first patient dosed with off-the-Shelf UCARTCS1 product candidate for relapsed/refractory multiple myeloma.
Verastem Oncology has reported $9 Million in total revenue, including $4.0 Million in net product revenue from COPIKTRA®; Reaffirms FY2019…